{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:28:47Z","timestamp":1781886527257,"version":"3.54.5"},"reference-count":71,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Neuroblastoma (NB), the most prevalent extracranial solid malignancy in children, poses significant therapeutic challenges, particularly concerning high-risk subtypes characterized by an immunologically \u201ccold\u201d phenotype. These tumors evade immune surveillance through mechanisms such as impaired antigen presentation and immunosuppressive microenvironment formation. Despite the incorporation of immunotherapies (<jats:italic>e.g.<\/jats:italic>, GD2 monoclonal antibodies) into international clinical guidelines, the 5-year survival rate of patients with NB persistently remains lower than 50%. Small-molecule targeted agents, distinguished by their low molecular weight and superior chemical stability, offer advantages over macromolecular antibody therapies by effectively penetrating cell membranes to engage intracellular targets. Epigenetic regulation, a DNA sequence-independent gene expression modulation system, plays a pivotal role in cell fate determination <jats:italic>via<\/jats:italic> dynamic DNA methylation, histone covalent modifications, chromatin spatial reorganization, and non-coding RNA-mediated pathways. Emerging evidence has highlighted a strong correlation between epigenetic dysregulation and NB progression, establishing a molecular rationale for novel therapeutic strategies. Current epigenetic research in NB primarily focuses on histone deacetylase inhibitors and DNA methyltransferase inhibitors. These drugs exhibit unique translational potential because of their accelerated development timelines and cost-effective production, significantly enhancing therapeutic accessibility. This review systematically examines the current landscape of epigenetic modulators in NB treatment and discusses their transformative potential in improving outcomes for high-risk patients with NB.<\/jats:p>","DOI":"10.3389\/fimmu.2025.1637626","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T05:26:30Z","timestamp":1753421190000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Emerging frontiers in epigenetic-targeted therapeutics for pediatric neuroblastoma"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiaokang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gengrui","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guiping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.fmre.2022.08.005","article-title":"Advances in liquid biopsy in neuroblastoma","volume":"2","author":"Zhuo","year":"2022","journal-title":"Fundam Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0804577","article-title":"Recent advances in neuroblastoma","volume":"362","author":"Maris","year":"2010","journal-title":"N Engl J Med."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2024.104898","article-title":"Natural killer cell-based therapies in neuroblastoma","volume":"407","author":"Ghasempour","year":"2025","journal-title":"Cell Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-24-0237","article-title":"Neuroblastoma predisposition and surveillance-an update from the 2023 AACR childhood cancer predisposition workshop","volume":"30","author":"Kamihara","year":"2024","journal-title":"Clin Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41571-022-00643-z","article-title":"Advancing therapy for neuroblastoma","volume":"19","author":"Qiu","year":"2022","journal-title":"Nat Rev Clin Oncol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-24-0046","article-title":"Identification and characterization of chemotherapy-resistant high-risk neuroblastoma persister cells","volume":"14","author":"Grossmann","year":"2024","journal-title":"Cancer Discov"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-025-02629-5","article-title":"Engineering innate immune cells for cancer immunotherapy","volume":"43","author":"Tarannum","year":"2025","journal-title":"Nat Biotechnol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2015.09.010","article-title":"WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma","volume":"10","author":"Masserot","year":"2016","journal-title":"Mol Oncol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"e105784","DOI":"10.15252\/embj.2020105784","article-title":"ALK ligand ALKAL2 potentiates MYCN-driven neuroblastoma in the absence of ALK mutation","volume":"40","author":"Boren\u00e4s","year":"2021","journal-title":"EMBO J"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI175310","article-title":"Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma","volume":"134","author":"Nagarajan","year":"2024","journal-title":"J Clin Invest"},{"key":"B11","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13148-025-01844-w","article-title":"Epigenetic marvels: exploring the landscape of colorectal cancer treatment through cutting-edge epigenetic-based drug strategies","volume":"17","author":"Tahghighi","year":"2025","journal-title":"Clin Epigenet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/s41571-019-0266-5","article-title":"The emerging role of epigenetic therapeutics in immuno-oncology","volume":"17","author":"Topper","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-020-09946-y","article-title":"Neuroblastoma and the epigenome","volume":"40","author":"Fetahu","year":"2021","journal-title":"Cancer Metastasis Rev"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.09.046","article-title":"Expression quantitative trait loci and receptor pharmacology implicate Arg1 and the GABA-A receptor as therapeutic targets in neuroblastoma","volume":"9","author":"Hackett","year":"2014","journal-title":"Cell Rep"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1200\/JCO-24-02407","article-title":"Frequency and clinical significance of clonal and subclonal driver mutations in high-risk neuroblastoma at diagnosis: A children\u2019s oncology group study","volume":"43","author":"Berko","year":"2025","journal-title":"J Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2021.108054","article-title":"Targeting RAS in neuroblastoma: Is it possible","volume":"236","author":"Lin","year":"2022","journal-title":"Pharmacol Ther"},{"key":"B17","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12943-021-01361-3","article-title":"CircMEMO1 modulates the promoter methylation and expression of TCF21 to regulate hepatocellular carcinoma progression and sorafenib treatment sensitivity","volume":"20","author":"Dong","year":"2021","journal-title":"Mol Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1002\/hep.31486","article-title":"Ten-eleven translocation 1 promotes Malignant progression of cholangiocarcinoma with wild-type isocitrate dehydrogenase 1","volume":"73","author":"Bai","year":"2021","journal-title":"Hepatology"},{"key":"B19","doi-asserted-by":"publisher","first-page":"27008","DOI":"10.1289\/EHP5862","article-title":"Role of TET dioxygenases and DNA hydroxymethylation in bisphenols-stimulated proliferation of breast cancer cells","volume":"128","author":"Li","year":"2020","journal-title":"Environ Health Perspect"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3892\/or.2019.7266","article-title":"\u03b22\u2212adrenergic receptor signaling promotes neuroblastoma cell proliferation by activating autophagy","volume":"42","author":"Deng","year":"2019","journal-title":"Oncol Rep"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6602094","article-title":"Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21\u201323 in the biology of favourable stage 4 tumours","volume":"91","author":"Mora","year":"2004","journal-title":"Br J Cancer"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-014-0354-5","article-title":"A rapid screening system evaluates novel inhibitors of DNA methylation and suggests F-box proteins as potential therapeutic targets for high-risk neuroblastoma","volume":"10","author":"Penter","year":"2015","journal-title":"Target Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1038\/s41592-022-01412-7","article-title":"A pan-tissue DNA methylation atlas enables in silico decomposition of human tissue methylomes at cell-type resolution","volume":"19","author":"Zhu","year":"2022","journal-title":"Nat Methods"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/cells10051001","article-title":"Broad-spectrum HDAC inhibitors promote autophagy through FOXO transcription factors in neuroblastoma","volume":"10","author":"K\u00f6rholz","year":"2021","journal-title":"Cells"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4161\/cc.9.9.11543","article-title":"Romidepsin (FK228\/depsipeptide) controls growth and induces apoptosis in neuroblastoma tumor cells","volume":"9","author":"Panicker","year":"2010","journal-title":"Cell Cycle"},{"key":"B26","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1038\/s41467-022-31645-1","article-title":"PRMT5 activates AKT via methylation to promote tumor metastasis","volume":"13","author":"Huang","year":"2022","journal-title":"Nat Commun"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1517\/14728220903241658","article-title":"Targeting of HDAC8 and investigational inhibitors in neuroblastoma","volume":"18","author":"Oehme","year":"2009","journal-title":"Expert Opin Investig Drugs"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1300113110","article-title":"Histone deacetylase 10 promotes autophagy-mediated cell survival","volume":"110","author":"Oehme","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.00703","article-title":"Randomized phase II trial of MIBG versus MIBG, vincristine, and irinotecan versus MIBG and vorinostat for patients with relapsed or refractory neuroblastoma: A report from NANT consortium","volume":"39","author":"DuBois","year":"2021","journal-title":"J Clin Oncol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2022.2075204","article-title":"TH-MYCN tumors, but not tumor-derived cell lines, are adrenergic lineage, GD2+, and responsive to anti-GD2 antibody therapy","volume":"11","author":"McNerney","year":"2022","journal-title":"Oncoimmunology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/ng.2628","article-title":"Proteomic and bioinformatic analysis of mammalian SWI\/SNF complexes identifies extensive roles in human Malignancy","volume":"45","author":"Kadoch","year":"2013","journal-title":"Nat Genet"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-025-02961-2","article-title":"Role of epigenetics in paediatric cancer pathogenesis & drug resistance","volume":"132","author":"Leung","year":"2025","journal-title":"Br J Cancer"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-21-0385","article-title":"EP300 selectively controls the enhancer landscape of MYCN-amplified neuroblastoma","volume":"12","author":"Durbin","year":"2022","journal-title":"Cancer Discov"},{"key":"B34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejca.2016.12.019","article-title":"Enhancer of zeste homologue 2 plays an important role in neuroblastoma cell survival independent of its histone methyltransferase activity","volume":"75","author":"Bate-Eya","year":"2017","journal-title":"Eur J Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/s41467-021-27609-6","article-title":"EZH2 depletion potentiates MYC degradation inhibiting neuroblastoma and small cell carcinoma tumor formation","volume":"13","author":"Wang","year":"2022","journal-title":"Nat Commun"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102600","article-title":"Review: targeting EZH2 in neuroblastoma","volume":"119","author":"Gao","year":"2023","journal-title":"Cancer Treat Rev"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1090989","article-title":"Epigenetics and endoplasmic reticulum in podocytopathy during diabetic nephropathy progression","volume":"13","author":"Wang","year":"2022","journal-title":"Front Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2024.111525","article-title":"Unveiling the hidden gem: A review of long non-coding RNA NBAT-1 as an emerging tumor suppressor and prognostic biomarker in cancer","volume":"126","author":"Sethi","year":"2025","journal-title":"Cell Signal"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1016\/j.fmre.2023.04.012","article-title":"Functions, mechanisms, and therapeutic implications of noncoding RNA in acute myeloid leukemia","author":"Wang","year":"2025","journal-title":"Fundam Res"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.1091847","article-title":"Recent advances in the roles of exosomal microRNAs in neuroblastoma","volume":"12","author":"Bhavsar","year":"2022","journal-title":"Front Oncol"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2019.09.017","article-title":"Nanotechnological based miRNA intervention in the therapeutic management of neuroblastoma","volume":"69","author":"Pottoo","year":"2021","journal-title":"Semin Cancer Biol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"eads2641","DOI":"10.1126\/scisignal.ads2641","article-title":"A drug that induces the microRNA miR-124 enables differentiation of retinoic acid-resistant neuroblastoma cells","volume":"18","author":"Nguyen","year":"2025","journal-title":"Sci Signal"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1177\/1533033820957622","article-title":"Comprehensive characterization of circular RNAs in neuroblastoma cell lines","volume":"19","author":"Zhang","year":"2020","journal-title":"Technol Cancer Res Treat"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S297316","article-title":"circRNA-TBC1D4, circRNA-NAALAD2 and circRNA-TGFBR3: Selected Key circRNAs in Neuroblastoma and Their Associations with Clinical Features","volume":"13","author":"Lin","year":"2021","journal-title":"Cancer Manag Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-06-0623","article-title":"Combined effects of retinoic acid and histone deacetylase inhibitors on human neuroblastoma SH-SY5Y cells","volume":"6","author":"De los Santos","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"B46","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/1471-2407-6-214","article-title":"Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio","volume":"6","author":"M\u00fchlethaler-Mottet","year":"2006","journal-title":"BMC Cancer"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjp.0707608","article-title":"Inhibitors of histone deacetylase (HDAC) restore the p53 pathway in neuroblastoma cells","volume":"153","author":"Condorelli","year":"2008","journal-title":"Br J Pharmacol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2004.05.010","article-title":"The novel histone deacetylase inhibitor BL1521 inhibits proliferation and induces apoptosis in neuroblastoma cells","volume":"68","author":"de Ruijter","year":"2004","journal-title":"Biochem Pharmacol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2005.03.016","article-title":"Antagonistic effects of sequential administration of BL1521, a histone deacetylase inhibitor, and gemcitabine to neuroblastoma cells","volume":"233","author":"de Ruijter","year":"2006","journal-title":"Cancer Lett"},{"key":"B50","doi-asserted-by":"publisher","first-page":"293","DOI":"10.4103\/1673-5374.265564","article-title":"Action of trichostatin A on Alzheimer\u2019s disease-like pathological changes in SH-SY5Y neuroblastoma cells","volume":"15","author":"Li","year":"2020","journal-title":"Neural Regener Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-11-0961","article-title":"EZH2 Mediates epigenetic silencing of neuroblastoma suppressor genes CASZ1, CLU, RUNX3, and NGFR","volume":"72","author":"Wang","year":"2012","journal-title":"Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejcb.2022.151238","article-title":"The PRC2 molecule EED is a target of epigenetic therapy for neuroblastoma","volume":"101","author":"Shaliman","year":"2022","journal-title":"Eur J Cell Biol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10142-025-01563-8","article-title":"Polycomb repressive complex 2 (PRC2) pathway\u2019s role in cancer cell plasticity and drug resistance","volume":"25","author":"Goleij","year":"2025","journal-title":"Funct Integr Genomics"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23073849","article-title":"Upregulation of p75NTR by histone deacetylase inhibitors sensitizes human neuroblastoma cells to targeted immunotoxin-induced apoptosis","volume":"23","author":"Dedoni","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2020.1817653","article-title":"Anti-GD2 antibody and Vorinostat immunocombination therapy is highly effective in an aggressive orthotopic neuroblastoma model","volume":"9","author":"van den Bijgaart","year":"2020","journal-title":"Oncoimmunology"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s12264-016-0052-7","article-title":"Expression profiles of SIRT1 and APP genes in human neuroblastoma SK-N-SH cells treated with two epigenetic agents","volume":"32","author":"Hou","year":"2016","journal-title":"Neurosci Bull"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.2174\/1568009623666230522113645","article-title":"The DNMT3B inhibitor nanaomycin A as a neuroblastoma therapeutic agent","volume":"23","author":"Izumi","year":"2023","journal-title":"Curr Cancer Drug Targets"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0906831106","article-title":"Epigenetic inactivation of the Sotos overgrowth syndrome gene histone methyltransferase NSD1 in human neuroblastoma and glioma","volume":"106","author":"Berdasco","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2014.10.015","article-title":"Protein arginine methyltransferase 5 is a key regulator of the MYCN oncoprotein in neuroblastoma cells","volume":"9","author":"Park","year":"2015","journal-title":"Mol Oncol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.28091","article-title":"MiR-137 functions as a tumor suppressor in neuroblastoma by downregulating KDM1A","volume":"133","author":"Althoff","year":"2013","journal-title":"Int J Cancer"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.febslet.2013.11.036","article-title":"miR-329 suppresses the growth and motility of neuroblastoma by targeting KDM1A","volume":"588","author":"Yang","year":"2014","journal-title":"FEBS Lett"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.1785","article-title":"The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1","volume":"5","author":"Tee","year":"2014","journal-title":"Oncotarget"},{"key":"B63","doi-asserted-by":"publisher","first-page":"e0125343","DOI":"10.1371\/journal.pone.0125343","article-title":"JARID1B expression plays a critical role in chemoresistance and stem cell-like phenotype of neuroblastoma cells","volume":"10","author":"Kuo","year":"2015","journal-title":"PloS One"},{"key":"B64","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1038\/s41419-022-05256-z","article-title":"LncRNA SNHG1 regulates neuroblastoma cell fate via interactions with HDAC1\/2","volume":"13","author":"Hsu","year":"2022","journal-title":"Cell Death Dis"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.253","article-title":"Histone deacetylase 5 blocks neuroblastoma cell differentiation by interacting with N-Myc","volume":"33","author":"Sun","year":"2014","journal-title":"Oncogene"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.106112","article-title":"Discovery of a 2,6-diarylpyridine-based hydroxamic acid derivative as novel histone deacetylase 8 and tubulin dual inhibitor for the treatment of neuroblastoma","volume":"128","author":"Tang","year":"2022","journal-title":"Bioorg Chem"},{"key":"B67","doi-asserted-by":"publisher","first-page":"10462","DOI":"10.1038\/s41598-020-67112-4","article-title":"Hydroxamic acid derivatives as HDAC1, HDAC6 and HDAC8 inhibitors with antiproliferative activity in cancer cell lines","volume":"10","author":"Sixto-L\u00f3pez","year":"2020","journal-title":"Sci Rep"},{"key":"B68","doi-asserted-by":"publisher","first-page":"e2635","DOI":"10.1038\/cddis.2017.49","article-title":"Neuroblastoma cells depend on HDAC11 for mitotic cell cycle progression and survival","volume":"8","author":"Thole","year":"2017","journal-title":"Cell Death Dis"},{"key":"B69","doi-asserted-by":"publisher","first-page":"e2400486","DOI":"10.1002\/ardp.202400486","article-title":"Utilization of an optimized AlphaFold protein model for structure-based design of a selective HDAC11 inhibitor with anti-neuroblastoma activity","volume":"357","author":"Baselious","year":"2024","journal-title":"Arch Pharm (Weinheim)"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2012.147","article-title":"The histone deacetylase SIRT2 stabilizes Myc oncoproteins","volume":"20","author":"Liu","year":"2013","journal-title":"Cell Death Differ"},{"key":"B71","doi-asserted-by":"publisher","first-page":"101017","DOI":"10.1016\/j.gendis.2023.05.016","article-title":"Chemotherapy-induced small extracellular vesicles prime the pre-metastatic niche to accelerate neuroblastoma metastasis","volume":"11","author":"Wills","year":"2024","journal-title":"Genes Dis"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1637626\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T05:26:31Z","timestamp":1753421191000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1637626\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":71,"alternative-id":["10.3389\/fimmu.2025.1637626"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1637626","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"article-number":"1637626"}}